Join Zoom Meeting
https://mc-meet.zoom.us/j/95861380114?pwd=WThqQ2ZxM1l5SlVVV1lWNUN4WTl0UT09

Meeting ID: 958 6138 0114
Passcode: 188969

MS-Autoimmune
Oliver, Tobin, M.B., B.Ch., B.A.O., Ph.D.
"Multiple Sclerosis - approaching a cure"

Learning objectives: 
Upon conclusion of this activity, participants will be able to:

• Identify expansion of the MS disease spectrum
• Review recent changes to MS prognosis
• Describe current MS treatment and monitoring paradigms
• Summarize future research directions

Dr. Tobin has the following relevant financial relationships to disclose: Grant or Research Support: Mallinckrodt Inc. and does intend to discuss the following off-label/investigative use of Pharmaceuticals Rituximab; Dimethylfumerate; Teriflunomide    

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.